We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$342M
AUM Growth
+$51.1M
(+18%)
Cap. Flow
+$47.6M
Cap. Flow
% of AUM
13.91%
Top 10 Holdings %
Top 10 Hldgs %
10.44%
Holding
675
New
141
Increased
130
Reduced
57
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$4.02M |
| 2 |
Nike
NKE
|
+$3.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$3.69M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$3.63M |
| 5 |
Costco
COST
|
+$3.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$3.04M |
| 2 |
Visa
V
|
+$2.98M |
| 3 |
Procter & Gamble
PG
|
+$2.96M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$2.94M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$2.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.97% |
| 2 | Industrials | 12.49% |
| 3 | Consumer Discretionary | 11.9% |
| 4 | Healthcare | 11.63% |
| 5 | Consumer Staples | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Jones Lang LaSalle
JLL
$15.8B
| $239K | 0.07% |
2,100
-2,000
| -49% | -$223K |
|
302
Hain Celestial
HAIN
$44.6M
| $238K | 0.07% |
6,700
+2,100
| +46% | +$92.1K |
|
|
SEE
303
DELISTED
Sealed Air
SEE
| $236K | 0.07% |
5,143
+2,700
| +111% | +$127K |
|
304
Ryanair
RYAAY
$30B
| $232K | 0.07% |
+7,743
| New | +$225K |
|
305
CME Group
CME
$95.4B
| $230K | 0.07% |
+2,200
| New | +$230K |
|
|
CTLT
306
DELISTED
CATALENT, INC.
CTLT
| $227K | 0.07% |
+8,800
| New | +$219K |
|
|
LN
307
DELISTED
LINE Corporation
LN
| $227K | 0.07% |
+4,700
| New | +$200K |
|
|
IMS
308
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $226K | 0.07% |
7,200
-6,400
| -47% | -$187K |
|
309
Chevron
CVX
$382B
| $222K | 0.06% |
2,158
-17,600
| -89% | -$1.8M |
|
310
Sinclair Inc
SBGI
$1.02B
| $222K | 0.06% |
7,700
-4,733
| -38% | -$137K |
|
311
Dollar Tree
DLTR
$24.8B
| $221K | 0.06% |
2,797
-3,000
| -52% | -$270K |
|
|
OCLR
312
DELISTED
Oclaro Inc.
OCLR
| $221K | 0.06% |
+25,800
| New | +$179K |
|
313
Vail Resorts
MTN
$5.7B
| $220K | 0.06% |
+1,400
| New | +$213K |
|
314
Steris
STE
$22.9B
| $219K | 0.06% |
3,000
-800
| -21% | -$56.5K |
|
315
Teleflex
TFX
$5.96B
| $218K | 0.06% |
+1,300
| New | +$233K |
|
|
HA
316
DELISTED
Hawaiian Holdings, Inc.
HA
| $217K | 0.06% |
4,473
-1,838
| -29% | -$83.4K |
|
317
Lumentum
LITE
$46.9B
| $209K | 0.06% |
+5,000
| New | +$164K |
|
|
SRCL
318
DELISTED
Stericycle Inc
SRCL
| $208K | 0.06% |
+2,600
| New | +$235K |
|
319
Ralph Lauren
RL
$22.4B
| $207K | 0.06% |
2,049
+1,100
| +116% | +$110K |
|
320
eBay
EBAY
$51.2B
| $205K | 0.06% |
+6,218
| New | +$188K |
|
321
Owens Corning
OC
$11B
| $203K | 0.06% |
3,799
-400
| -10% | -$21.5K |
|
322
Parker-Hannifin
PH
$120B
| $201K | 0.06% |
1,600
-2,000
| -56% | -$238K |
|
323
Occidental Petroleum
OXY
$55.7B
| $200K | 0.06% |
+2,749
| New | +$206K |
|
324
Compañía de Minas Buenaventura
BVN
$7.68B
| $199K | 0.06% |
14,400
-12,700
| -47% | -$178K |
|
325
Barclays
BCS
$87.8B
| $107K | 0.03% |
+13,091
| New | +$103K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Seven Eight Capital held 675 positions worth $342M, up 18% from $291M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $47.6M of net new capital in Q3 2016, opening 141 new positions and adding to 130 existing holdings. Its largest new stake was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Mastercard, an estimated $2.55M trimmed.
- Seven Eight Capital's largest Q3 2016 buy was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
- Seven Eight Capital added most to Bristol-Myers Squibb in Q3 2016, an estimated $3.69M increase.
- Seven Eight Capital's biggest Q3 2016 reduction was Mastercard, cutting an estimated $2.55M.
- Seven Eight Capital fully exited PNC Financial Services in Q3 2016, selling an estimated $3.04M.
- Seven Eight Capital's ten largest holdings make up 10% of its $342M portfolio in Q3 2016.
- Seven Eight Capital opened 141 new positions and closed 344 in Q3 2016.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $342M.
Based on Seven Eight Capital's 13F filing for Q3 2016, filed 14 Nov 2016.